Zobrazeno 1 - 5
of 5
pro vyhledávání: '"329"'
Autor:
Alok A. Khorana, Fahrettin Covut, Yihong Zhou, Shafia Rahman, Shab E Gul Rahim, Sudha Amarnath
Publikováno v:
Blood. 132:1242-1242
Background:Venous thromboembolism (VTE) is a highly prevalent complication of cancer and its treatment and is commonly treated with anticoagulation1. However, there are limited data regarding the use of therapeutic anticoagulation in patients with br
Autor:
Auro Viswabandya, Hans A. Messner, Dennis Dong Hwan Kim, Jieun Uhm, Marc Poch Martell, Elizabeth Shin, Jeffrey H. Lipton, Fotios V. Michelis
Publikováno v:
Blood. 126:3139-3139
Introduction: Chronic graft versus host disease (cGVHD) is one of the major complications after allogeneic hematopoietic cell transplantation (allo-HCT). Several prognostic factors have been proposed to predict the outcomes of cGVHD including progres
Autor:
Nicola Vianelli, Francesca Palandri, Margherita Perricone, Massimo Breccia, Nicola Polverelli, Roberto Latagliata, Emanuela Ottaviani, Michele Cavo, Giuseppe A. Palumbo, Lucia Catani, Giuliana Alimena, Francesco Merli, Giovanni Martinelli, Alessia Tieghi
Publikováno v:
Blood. 126:1614-1614
Introduction It is acknowledged that an accurate histological diagnosis may distinguish Essential Thrombocythemia (ET) from early Primary Myelofibrosis (early-PMF), which is projected to worse outcome in terms of survival and disease evolution into a
Autor:
Andrea Bacigalupo, Gérard Socié, Meral Beksac, Nigel H. Russell, Birte Friedrichs, Norbert Schmitz, Tapani Ruutu, Andre Tichelli
Publikováno v:
Blood. 112:451-451
In 2002, the EBMT reported on the largest prospective randomized study comparing filgrastim-mobilized peripheral blood progenitor cell (PBPC) to bone marrow (BM) transplantation (Schmitz et al. Blood 2002). Patient accrual took place between 02/95 an
Autor:
Chatchada Karanes, Tang-Her Jaing, Stephen J. Forman, M. Graham, Ah Moy Tan, Patrick Tan, Brian Wang, Gretchen Eames, Auayporn Nademanee, Joseph Rosenthal, Hai Peng Lin, Lawrence Petz, David W. Gjertson, Tiffany Chow, Lee Lee Chan, Robert Chow, Tina Wu
Publikováno v:
Blood. 112:4406-4406
Unrelated cord blood (UCB) is an important stem cell source for unrelated hematopoietic cell transplantation of patients with non-malignant disorders. Cell dosage is a critical factor for successful UCB hematopoietic stem cell transplantation (HSCT).